Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1988;77:787-794

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horowitz, J. D.
Right arrow Articles by Antman, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horowitz, J. D.
Right arrow Articles by Antman, E. M.

Circulation, Vol 77, 787-794, Copyright © 1988 by American Heart Association


ARTICLES

Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris

JD Horowitz, CA Henry, ML Syrjanen, WJ Louis, RD Fish, TW Smith and EM Antman
Department of Cardiology, Austin Hospital, Heidelberg, Victoria, Australia.

The vasodilator effects of nitroglycerin (NTG) are mediated via activation of guanylate cyclase; this process is believed to require the availability of free sulfhydryl groups. Previous studies in man have shown that the sulfhydryl donor N-acetylcysteine (NAC) potentiates the systemic and coronary vasodilator effects of NTG. Furthermore, interaction of NTG and NAC may lead to the formation of S-nitroso-NAC, which strongly inhibits platelet aggregation. The effects of intravenous NTG combined with intravenous NAC (5 g 6 hourly) were compared with those of intravenous NTG alone in a double-blind trial in 46 patients with severe unstable angina pectoris unresponsive to conventional treatment, which included calcium antagonists and cutaneous nitrates in all but one patient. Treatment with NTG/NAC (24 patients) and that with NTG alone (22 patients) was associated with a similar frequency of episodes of chest pain and of increments in NTG infusion rate for pain control (10 vs 17; p = NS). The NTG/NAC group had a significantly lower incidence of acute myocardial infarction than the NTG/placebo group (three vs 10 patients; p = .013). Symptomatic hypotension occurred frequently in the NTG/NAC group (seven vs 0 patients; p = .006). Lactate-pyruvate ratios and venous NTG concentrations were not significantly affected by NAC. Subsequently, another 20 consecutive patients were treated with intravenous NTG and continuously infused NAC (10 g/day). Seven remained pain free during the first 24 hr of NTG infusion; 11 required increments in NTG infusion rate for pain control. Acute myocardial infarction occurred in one patient, while none developed symptomatic hypotension.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Eur Heart JHome page
M. Ozaydin, O. Peker, D. Erdogan, S. Kapan, Y. Turker, E. Varol, F. Ozguner, A. Dogan, and E. Ibrisim
N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study
Eur. Heart J., March 1, 2008; 29(5): 625 - 631.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sochman
N-acetylcysteine in acute cardiology: 10 years later: What do we know and what would we like to know?!
J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1422 - 1428.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. P. Andrews, A. Prasad, and A. A. Quyyumi
N-acetylcysteine improves coronary and peripheral vascular function
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 117 - 123.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Prasad, N. P. Andrews, F. A. Padder, M. Husain, and A. A. Quyyumi
Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 507 - 514.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Hebert, J.-X. Xiang, and J. Y.T. Lam
Persistent Inhibition of Platelets During Continuous Nitroglycerin Therapy Despite Hemodynamic Tolerance
Circulation, March 4, 1997; 95(5): 1308 - 1313.
[Abstract] [Full Text]


Home page
CirculationHome page
M. A. Arstall, J. Yang, I. Stafford, W. H. Betts, and J. D. Horowitz
N-Acetylcysteine in Combination With Nitroglycerin and Streptokinase for the Treatment of Evolving Acute Myocardial Infarction : Safety and Biochemical Effects
Circulation, November 15, 1995; 92(10): 2855 - 2862.
[Abstract] [Full Text]